Ligand Pharmaceuticals (LGNDV)
NASDAQ: LGNDV
· Real-Time Price · USD
50.00
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM
Ligand Pharmaceuticals Revenue
Ligand Pharmaceuticals reported an annual revenue of $167.13M, reflecting a 27.28% growth. For the quarter ending June 30, 2025, Ligand Pharmaceuticals generated $47.63M in revenue.
Revenue (ttm)
167.13M
Revenue Growth
27.28%
Price / Sales Ratio
11.73
Revenue / Employee
1.09M
Employees
154
Market Cap
0
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 167.13M | +27.28% |
| Dec 31, 2023 | 131.31M | -33.09% |
| Dec 31, 2022 | 196.25M | -29.19% |
| Dec 31, 2021 | 277.13M | +48.66% |
| Dec 31, 2020 | 186.42M | +54.98% |
| Dec 31, 2019 | 120.28M | -52.17% |
| Dec 31, 2018 | 251.45M | +78.21% |
| Dec 31, 2017 | 141.1M | +29.48% |
| Dec 31, 2016 | 108.97M | +51.53% |
| Dec 31, 2015 | 71.91M | +11.43% |
| Dec 31, 2014 | 64.54M | +31.78% |
| Dec 31, 2013 | 48.97M | +56.03% |
| Dec 31, 2012 | 31.39M | +4.50% |
| Dec 31, 2011 | 30.04M | +27.61% |
| Dec 31, 2010 | 23.54M | -39.55% |
| Dec 31, 2009 | 38.94M | +42.56% |
| Dec 31, 2008 | 27.32M | +111.84% |
| Dec 31, 2007 | 12.89M | -90.85% |
| Dec 31, 2006 | 140.96M | -20.18% |
| Dec 31, 2005 | 176.61M | +8.01% |
| Dec 31, 2004 | 163.51M | +15.85% |
| Dec 31, 2003 | 141.14M | +46.05% |
| Dec 31, 2002 | 96.64M | +26.59% |
| Dec 31, 2001 | 76.34M | +58.68% |
| Dec 31, 2000 | 48.11M | +17.63% |
| Dec 31, 1999 | 40.9M | +131.07% |
| Dec 31, 1998 | 17.7M | -65.76% |
| Dec 31, 1997 | 51.7M | +40.49% |
| Dec 31, 1996 | 36.8M | +50.20% |
| Dec 31, 1995 | 24.5M | +84.21% |
| Dec 31, 1994 | 13.3M | n/a |